Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Strongbridge Biopharma plc (SBBP)

Income Statement Business | Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-21Mar-31-21Dec-31-20Sep-30-20Jun-30-20Mar-31-20Dec-31-19Sep-30-19
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Revenues  10.08.48.28.17.86.75.65.7
            Revenue growth  29.4%25.6%46.7%42.0%27.7%53.7%24.2%6.3%
Cost of goods sold  0.50.40.40.40.41.01.01.0
Gross profit  9.68.07.87.77.45.74.64.7
            Gross margin  95.3%95.1%94.6%94.9%94.9%85.5%82.4%82.4%
Selling, general and administrative   [+]16.010.911.69.29.610.412.012.8
Research and development  5.45.85.36.86.27.68.07.6
EBITDA   [+]-11.8-8.8-9.1-8.3-8.4-12.2-15.4-15.7
            EBITDA margin  -117.4%-104.9%-110.9%-102.9%-108.3%-183.2%-274.0%-275.4%
Depreciation  0.00.00.00.00.00.00.00.0
EBITA  -11.8-8.8-9.1-8.3-8.4-12.3-15.4-15.7
            EBITA margin  -117.6%-105.2%-111.1%-103.2%-108.5%-183.5%-274.3%-275.8%
Amortization of intangibles  1.31.31.31.31.31.31.31.3
EBIT   [+]-13.1-10.1-10.4-9.6-9.7-13.5-16.6-16.9
            EBIT margin  -130.1%-120.1%-126.4%-118.7%-124.7%-202.4%-296.7%-297.9%
Interest expense  0.80.80.60.50.3   
Other income (expense), net   [+]0.6-1.0-1.06.9-7.30.87.73.8
Pre-tax income  -13.2-11.8-12.0-3.2-17.3-12.7-9.0-13.1
Income taxes  0.00.00.00.00.00.00.00.7
            Tax rate   0.0%0.1%0.0%0.0%0.0%0.0% 
Net income  -13.2-11.8-11.9-3.2-17.3-12.7-20.4-13.8
            Net margin  -131.9%-140.9%-145.2%-39.1%-222.6%-190.3%-363.3%-242.6%
   
Basic EPS   [+]($0.20)($0.18)($0.21)($0.06)($0.32)($0.23)($0.38)($0.25)
Diluted EPS   [+]($0.19)($0.18)($0.21)($0.06)($0.32)($0.23)($0.37)($0.25)
   
Shares outstanding (basic)   [+]67.767.458.056.154.354.254.254.2
Shares outstanding (diluted)   [+]67.967.458.057.454.354.455.454.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy